The Food and Drug Administration is implementing more rigorous standards for administering the COVID-19 vaccine and experts are worried.

Hawaii island health professionals are concerned changes to U.S. Food and Drug Administration rules for COVID-19 vaccines ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...

The Delhi government has issued an advisory directing hospitals to ensure readiness for COVID-19 by securing beds, oxygen, ...

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated ...

Low uptake may reflect barriers—misinformation, access or shifting insurance coverage—not simply waning need.

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Vaccine opponents and skeptics in charge of federal health agencies are restricting access to COVID shots that were a signature accomplishment of President Donald Trump’s first term.